DailyIQ
Last updated1 minute ago

EFX·Equifax Inc.

$142.46
-0.02 (-0.01%)
High
$143.80
Open
$143.12
Market Cap
16.62B
52W High
$245.00
Low
$140.84
P. Close
$142.46
P/E
24.04
52W Low
$131.50
Fwd P/E
14.08
DailyIQ Est.
$215.06
Inst. Ownership
48.7%
Short Interest
6.65%
Days to Cover
5.6
Technical Score (1D)
18
BEARISH
News Sentiment
44
BEARISH
On Oct 7, Rothschild & Co Redburn lowered its price target for Equifax (EFX) to $213 from $235, signaling a modest negative shift in sentiment toward the company’s valuation prospects. The firm maintained an average rating of overweight while adjusting the mean target downward. Analysts cited a need for stronger earnings growth and tighter margin expectations as reasons for the lower target. The downgrade reflects a more cautious outlook on Equifax’s future performance.
LOW TARGET
$148 +3.9%
2 analysts
MEAN TARGET
$207 +45.3%
17 analysts
HIGH TARGET
$245 +72.0%
13 analysts
PRICE RANGE
$148.00 - $245.00
SB / B / H / S / SS
8/13/9/1/1
DAILYIQ EST.
$215.06 (+51.0%)
Sector
Industrials
Industry
Consulting Services
Exchange
NYQ
Country
United States
Symbol
EFX
Description
Equifax is a data and analytics firm that provides critical information solutions globally. The company's core business revolves around three primary segments: Workforce Solutions, U.S. Information Solutions, and International. Workforce Solutions offers services that help employers with employment verification and human resource management, while U.S. Information Solutions provides credit information, fraud detection, and identity verification services to both consumers and businesses. The International segment delivers similar information and services, including credit scoring and marketing solutions, across numerous countries including the United States, Canada, and the United Kingdom. Equifax's long history, dating back to 1899, and diverse geographic presence position it as a key player in the information services landscape.
Bought (1Y)
0 shares
$0
Sold (1Y)
41,691 shares
$7.3M
Larson Barbara A-
Award/Grant209 shares2026-09-30
MARCUS ROBERT D-
Award/Grant255 shares2026-09-30
GAMBLE JOHN W JREVP, CFO & COO
Sell4,500 shares2026-09-03
Larson Barbara A-
Award/Grant160 shares2026-08-10
Larson Barbara A-
Award/Grant181 shares2026-08-10
76/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Net Margin
10.9%
Revenue CAGR
7.4%
Current Ratio
0.60x
Debt / Equity
1.11x
Return on Equity
14.3%
Earnings Summary
Equifax is a global data and analytics firm that delivers workforce, credit, fraud detection, and identity verification services across the United States, Canada, and the United Kingdom, positioning it as a key player in the information services landscape within the industrials sector. In the most recent quarters, the company posted EPS of $2.12 in Q4 2024, $1.53 in Q1 2025, $2.00 in Q2 2025, and $2.04 in Q3 2025, all of which exceeded analyst expectations, indicating a consistent ability to beat earnings estimates. Revenue grew from $1.4194 billion in Q4 2024 to $1.542 billion in Q3 2025, a year‑over‑year increase of roughly 8.5%, while Q1 2026 revenue fell to $1.6489 billion, slightly below the $1.6926 billion estimate, and Q2 2026 revenue rose to $1.7001 billion, again beating the $1.7134 billion forecast. The company has maintained a pattern of EPS beats in the last four quarters, though revenue has shown a modest slowdown in Q1 2026 before rebounding in Q2 2026. Historically, Equifax has delivered double‑digit revenue growth over the past three years, with EPS growth outpacing revenue in most periods, reflecting strong profitability. The company’s recent news highlights the launch of 54 AI‑enabled products in the first half of 2026 and a 16% Vitality Index in Q2, surpassing its full‑year target, which underscores a strategic shift toward proprietary AI offerings. However, regulatory changes such as the adoption of VantageScore by Fannie Mae and Freddie Mac may introduce competitive pressure on its mortgage credit reporting services.

EPS

EstBeatMiss
$1.28$1.55$1.83$2.10$2.38Q1'25Q2'25Q3'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$2.22 - -
Q2'26$2.20$2.25+2.3%
Q1'26$2.22$1.86-16.3%
Q3'25$1.94$2.04+5.3%
Q2'25$1.92$2.00+4.1%
Q1'25$1.40$1.53+9.0%

Revenue

EstBeatMiss
$1.4B$1.5B$1.6B$1.7B$1.8BQ1'25Q2'25Q3'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.7B - -
Q2'26$1.7B$1.7B-0.8%
Q1'26$1.7B$1.6B-2.6%
Q3'25 - $1.5B -
Q2'25 - $1.5B -
Q1'25 - $1.4B -

Market Data

EFX Stock Snapshot

BEARISH18/100
$142.46−$0.02 (0.0%)
Market cap
16.62B
P/E ratio
24.0
Day range
$140.84 – $143.80
News sentiment
44/100 · Neutral
Analyst target
$207.05 (+45.3%)
Consensus
Buy · 32 analysts
52-week range+8.3% off low · -41.9% from high
$131.50$245.00
Price $142.46 DailyIQ Est. $215.06

EFX is on the weaker side of its setup, with little confirmation for a reversal yet. In Industrials, names this size usually take direction from sector flows before company-level news.

Reverse DCF

What growth is priced into EFX?

FAIR

At today's price, Equifax Inc. needs to grow free cash flow about 5.1% a year for the next 10 years to justify its valuation at a 8.37% cost of capital. Over its actual history it has compounded free cash flow at 4.0% a year, so the market is asking for 1.1 percentage points above its own delivered rate. On that basis EFX looks priced roughly in line with its own growth record.

Implied FCF growth
5.1%
Historical FCF CAGR
4.0%
Growth gap
+1.1 pts
Verdict
FAIR
Discount rate (WACC)
8.37%
Beta
0.95

Behaviour On Record

What EFX's own history says about today's numbers

Realized volatility (21d)
34.2% 78th pct
Below its peak
-53.6%
vs 200-day average
-21.8%
Up days (1y)
48%

Equifax Inc. is currently running 34.2% annualised volatility over the last 21 sessions. Measured against EFX's own 13 years of daily returns rather than a market-wide average, that is the 78th percentile — elevated for this stock, against a typical reading of 23.8%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

EFX is trading -53.6% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -24.0%, and the deepest was -47.6% in 2022. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.

Price sits -21.8% from its 200-day moving average. Against every other day in its history, that gap ranks at the 3rd percentile — a narrower gap than it typically runs. Over the past year EFX closed higher on 48% of sessions, and it is currently 3 sessions into a rising streak.

On October specifically: over 13 years of records, EFX finished the month higher 5 of 13 times, with a median return of -2.2% and an average of -3.2%. Its strongest month historically has been November at +5.4% on average, its weakest September at -6.9%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: EFX has opened more than 2% away from the prior close in 104 of 3,267 sessions (3.2% of the time), with the largest gaps running +28.0% and -8.5%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

All figures computed from 3,268 daily closes between 2013-10-07 and 2026-10-05, split-adjusted, recomputed daily. Percentiles are against EFX's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of EFX's sector?

Equifax Inc. sits in the Industrials sector, currently ranked 8th of 12 GICS sectors by relative-strength rotation score (improving).

Sector rank
#8 of 12
Sector state
Improving
Sector rotation score
9

Options Market

What is the options market pricing for EFX?

CallsPuts

For Equifax Inc.'s nearest expiry (2026-10-16, 9 days out), open interest is put-heavy, a defensive/bearish tilt (put/call ratio of 3.82), with at-the-money implied volatility around 50.7%. The options market is pricing roughly a ±7.4% move by that expiry — a range of about $131.65–$152.81.

Put/call ratio (2026-10-16)
3.82
ATM implied volatility
50.7%
Total open interest
3,049
Expected move by 2026-10-16
±7.4% ($131.65–$152.81)

Analyst Rating Changes

Are analysts turning bullish or bearish on EFX?

Barclays most recently reiterated its rating on Equifax Inc. to Equal-Weight on Oct 2, 2026 with a price target of $155 (from $200). Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.

Latest action
Barclays — Equal-Weight
90-day upgrades
1
90-day downgrades
0
Net rating momentum
+1
DateFirmActionRatingPrice target
Oct 2, 2026BarclaysMaintainedEqual-Weight$200 → $155
Sep 30, 2026BMO CapitalMaintainedMarket Perform$179 → $160
Sep 22, 2026Wells FargoMaintainedOverweight$212 → $200
Aug 21, 2026Rothschild & CoUpgradeNeutral → Buy$214 → $235
Jul 22, 2026Wells FargoMaintainedOverweight$220 → $212
Jul 22, 2026Morgan StanleyMaintainedOverweight$243 → $225
Jul 22, 2026BairdMaintainedOutperform$245 → $232
Jul 22, 2026RBC CapitalMaintainedOutperform$222 → $194
Jul 22, 2026BarclaysMaintainedEqual-Weight$215 → $200
Jul 22, 2026NeedhamMaintainedBuy$265 → $245
Jul 8, 2026UBSReiteratedBuy$220
Jul 7, 2026NeedhamReiteratedBuy$265

EFX Competitive Positioning

Equifax Inc. (EFX) is tracked alongside these names in Consulting Services on DailyIQ — ranked by market cap, with today's move alongside.

News Sentiment Analysis

Sentiment gathered from recent headlines

44/100
Strong NegativeNeutralStrong Positive
BEARISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Rothschild & Co Redburn reduced its price target for Equifax (EFX) to $213 from $235, reflecting a more cautious outlook. The downgrade came after the firm’s average rating of overweight remained unchanged, but the mean target was adjusted downward. Analysts cited a need for stronger earnings growth and tighter margin expectations as reasons for the lower target. The move signals a modest negative shift in sentiment toward EFX’s valuation prospects.
What did this article say?
Deutsche Bank reduced its price target for Equifax (EFX) from $208 to $179 while keeping a buy rating. The downgrade reflects concerns over the company’s earnings outlook and competitive pressures. The adjustment signals a more cautious view of EFX’s growth prospects, potentially impacting investor sentiment.
What did this article say?
Equifax reported that its AI‑enabled products and proprietary data are fueling growth, with 54 new AI offerings launched in the first half of 2026. The company’s Vitality Index reached 16% in Q2, surpassing its 15% full‑year target. International expansion and improving margins are expected to provide additional earnings leverage, while strong free cash flow offers flexibility for acquisitions, debt reduction and shareholder returns. Elevated mortgage rates and higher short‑term borrowing could constrain transaction growth, but the firm remains confident in sustained cash generation and funding‑market access.
What did this article say?
Equifax announced that it will release its third‑quarter 2026 financial results on October 20, 2026, at 6:30 a.m. ET, followed by a conference call at 8:30 a.m. ET. The company will provide a presentation and audio replay of the call on its investor website. The announcement is a routine disclosure with no immediate impact on the company’s outlook.
What did this article say?
Baird Research lowered its price target for Equifax (EFX) from $232 to $193 while keeping an outperform rating. The downgrade reflects concerns over the company’s earnings outlook and competitive pressures in the credit reporting industry. The new target suggests a more cautious view of EFX’s valuation, potentially impacting investor sentiment. The rating remains positive, indicating Baird still believes the stock has upside potential. The adjustment signals a modest negative shift in analyst consensus.
What did this article say?
Barclays reduced its price target for Equifax (EFX) from $200 to $155 while maintaining an equal‑weight rating. The downgrade reflects a reassessment of the company’s valuation relative to peers. The new target suggests a more cautious outlook on EFX’s earnings prospects. The change is expected to influence investor sentiment and could pressure the stock price. The rating adjustment signals a shift in analyst consensus about the company’s growth potential.
What did this article say?
Barclays analyst Manav Patnaik reduced Equifax’s (EFX) price target from $200 to $155 while keeping an equal‑weight recommendation. The downgrade reflects concerns over the company’s earnings outlook and competitive pressures in the credit‑reporting sector. The move signals a modest negative view for investors, though the rating level remains unchanged. This adjustment may influence short‑term trading activity but is not expected to trigger a significant market shift.
What did this article say?
Equifax (EFX) is confronting fresh competition as Fannie Mae and Freddie Mac plan to incorporate VantageScore into mortgage underwriting by 2026. The Federal Housing Finance Agency will mandate a single pricing grid for both VantageScore and FICO models, potentially reducing demand for traditional Equifax mortgage credit reports. Major originators, including Rocket Mortgage, are preparing to adopt the dual‑score framework, which could shift Equifax’s fee mix and volume dynamics. The change may erode Equifax’s market share in mortgage‑related credit reporting, though the full impact remains uncertain.
What did this article say?
Equifax Inc. (EFX) was expected to report its third‑quarter earnings on September 30, 2026, with analysts forecasting a single‑digit percentage increase in net income. The company’s projected earnings per share were $2.21, up 8.3% from $2.04 in the same quarter a year earlier. Historically, EFX has consistently exceeded Street estimates for four consecutive quarters, underscoring a track record of earnings strength. The anticipated earnings beat suggests continued resilience in its data‑analytics business amid competitive pressures. The forecasted growth is viewed as a positive catalyst for the stock, reflecting confidence in the company’s revenue mix and cost management.

Technical Analysis

Real-time indicators across multiple timeframes

18
BEARISH
Technical indicators reflect the latest computed signal mix for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $9.79B combined position · 10 adding, 12 trimming, 3 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
Vanguard Group Inc▼ Sell14,965,46212.83%$3.25B2026-01-29
BlackRock, Inc.▼ Sell9,396,1508.06%$1.49B2026-08-07
Harris Associates L P▼ Sell7,447,2636.39%$1.18B2026-08-14
Morgan Stanley▼ Sell3,310,9572.84%$525.52M2026-08-13
Geode Capital Management, LLC▼ Sell3,155,7532.71%$498.85M2026-08-12
AQR Capital Management LLC▲ Buy2,669,0742.29%$415.92M2026-08-14
Invesco Ltd.▲ Buy2,000,2281.72%$317.48M2026-08-14
Norges Bank▲ Buy1,535,1111.32%$243.65M2026-08-12
Egerton Capital (UK) LLP• Hold1,481,1881.27%$235.09M2026-07-21
FMR LLC (Fidelity)▼ Sell1,349,8171.16%$214.24M2026-08-13
Bank of America Corp▼ Sell1,179,5321.01%$187.22M2026-08-14
Goldman Sachs Group Inc▲ Buy1,104,9890.95%$175.38M2026-08-14
Northern Trust Corp▲ Buy1,081,4760.93%$171.65M2026-08-13
Junto Capital Management LP• Hold645,5250.55%$140.07M2026-02-17
Marshall Wace, LLP▲ Buy681,9190.58%$108.23M2026-08-13
Citigroup Inc▲ Buy658,7270.56%$104.55M2026-08-03
Capital World Investors▼ Sell627,3030.54%$99.57M2026-08-12
Man Group plc▲ Buy517,1020.44%$82.07M2026-08-14
Wells Fargo & Company▼ Sell477,6900.41%$75.82M2026-08-14
JPMorgan Chase & Co▼ Sell381,1860.33%$60.44M2026-08-12
Neuberger Berman Group LLC▼ Sell335,6450.29%$53.27M2026-08-13
Citadel Advisors LLC• Hold316,6180.27%$50.25M2026-09-02
D. E. Shaw & Co., Inc.▲ Buy313,4520.27%$49.75M2026-08-14
Millennium Management LLC▼ Sell224,7130.19%$35.67M2026-08-14
Two Sigma Investments, LP▲ Buy167,6050.14%$26.60M2026-08-14
Q2 2026 flow:4.30M sh bought ($680.16M)2.51M sh sold ($398.96M)net +1.79M sh (+$281.21M)
Congressional Trading Activity
4 disclosed trades · ~$32.0K est. traded value · 2 buys, 2 sells
MemberChamberStateTypeAmountTradedFiled
Gilbert CisnerosHouseCA31▼ Sell$1K - $15K2026-04-142026-05-08
Gilbert CisnerosHouseCA31▲ Buy$1K - $15K2026-03-132026-04-07
Rob BresnahanHousePA08▲ Buy$1K - $15K2025-04-082025-05-08
Byron DonaldsHouseFL19▼ Sell$1K - $15K2025-03-202025-04-14